Stage 4 and Metastatic Cancer · LIVING RESEARCH LIBRARY

Ongoing Research for Stage 4 and Metastatic Cancer Using Advanced Alternative Medicine

Explore positive published findings by substance, cancer biology, treatment interaction and quality-of-life outcome.

Every entry includes the original study title, year, concise finding and a direct PubMed link.

Call 1.800.923.7878

Ask About Your Stage 4 and Metastatic Cancer Case

Tell us the diagnosis, stage, biomarkers, current treatment plan and research questions you want to understand. Our Patient Care Team will follow up personally.

Prefer to speak now?
Call 1.800.923.7878

Explore this cancer section

Stage 4 & Metastatic Cancer

Living research library · positive published findings

Research organized by substance and finding

Browse 80 source-linked studies with the full title, publication year, research focus and a concise finding. Select any linked substance to move directly to its corresponding Sunridge page.

[Dihydroartemisinin inhibits the progression of oral squamous cell carcinoma].

2026 · Metastasis and invasion

Bioinforma-tics analysis showed that the survival rate of patients with extracapsular spread and metastasis in tumor tissues was lower than that of patients without such phenomena (P<0.05).

Open study on PubMed →

Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins.

2025 · Metastasis and invasion

Artesunate (ART) a derivative of artemisinin, used in Traditional Chinese Medicine, shows anti-tumor activity extending over a broad spectrum of human cancers.

Open study on PubMed →

Dihydroartemisinin inhibits EMT of glioma via gene BASP1 in extrachromosomal DNA.

2023 · Metastasis and invasion

The mechanism of dihydroartemisinin (DHA) inhibiting the migration and invasion of glioma in an ROS-DSB-dependent manner has been revealed.

Open study on PubMed →

Dihydroartemisinin inhibits galectin-1-induced ferroptosis resistance and peritoneal metastasis of gastric cancer via the Nrf2-HO-1 pathway.

2025 · Metastasis and invasion

This study investigated the role and mechanism of galectin-1 within the GC microenvironment in promoting PM and evaluated the inhibitory effects of dihydroartemisinin(DHA) on galectin-1-induced PM.

Open study on PubMed →

Dihydroartemisinin inhibits HNSCC invasion and migration by controlling miR-195-5p expression.

2024 · Metastasis and invasion

Dihydroartemisinin (DHA), an artemisinin derivative extracted from the traditional Chinese medicinal herb Artemisia annua, has the potential to suppress head and neck squamous cell carcinoma (HNSCC) progression.

Open study on PubMed →

Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition.

2020 · Metastasis and invasion

It has been demonstrated from previous studies about the killing effect of dihydroartemisinin (DHA) on glioblastoma, which involves multiple aspects: cytotoxicity, cell cycle arrest and invasion inhibition.

Open study on PubMed →

A specific super-enhancer actuated by berberine regulates EGFR-mediated RAS-RAF1-MEK1/2-ERK1/2 pathway to induce nasopharyngeal carcinoma autophagy.

2024 · Metastasis and invasion

In clinic, the berberine (BBR) compound has widely been in NPC therapy to decrease metastasis and disease recurrence, and BBR was documented as a main component with multiple anti-NPC effects.

Open study on PubMed →

Berberine inhibits glioma cell migration and invasion by suppressing TGF-β1/COL11A1 pathway.

2022 · Metastasis and invasion

In previous studies, we demonstrated that berberine inhibits glioma cell proliferation by inhibiting mutant p53 protein and promoting mitochondrial damage.

Open study on PubMed →

Berberine is a suppressor of Hedgehog signaling cascade in colorectal cancer.

2023 · Metastasis and invasion

Berberine was discovered to suppress the proliferation, migration, invasion and clonogenesis of HCT116 cells and SW480 cells.

Open study on PubMed →

Berberine Reverses the Tumorigenic Function of Colon Cancer Cell-Derived Exosomes.

2023 · Metastasis and invasion

In conclusion, berberine can reverse the tumorigenic function of colon cancer exosomes and, thus, exert a remarkable suppressive impact against the survival and metastatic ability of colon cancer cells.

Open study on PubMed →

Berberine-mediated Ferroptosis through System Xc-/GSH/GPX4 Axis Inhibits Metastasis of Nasopharyngeal Carcinoma.

2024 · Metastasis and invasion

Here, we showed that BBR exerted its anti-metastasis role by inhibiting system Xc-/GSH/GPX4 axis-driven ferroptosis.

Open study on PubMed →

Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis.

2023 · Metastasis and invasion

Deletion of miR-34a and miR-34b/c significantly reduced curcumin-induced apoptosis and senescence, and prevented the inhibition of migration and invasion by curcumin or ectopic NRF2.

Open study on PubMed →

Curcumin exerts therapeutic effects on colorectal cancer by inducing pyroptosis through caspase‑1 activation.

2025 · Metastasis and invasion

Curcumin significantly reduced CRC cell viability, migration and invasion in a dose‑dependent manner.

Open study on PubMed →

Curcumin Increases Radiosensitivity of Radioresistant Nasopharyngeal Cancer.

2023 · Metastasis and invasion

Curcumin treatment significantly inhibited the proliferation and invasion of C6661-IR cells, promoted apoptosis and enhanced radiosensitivity.

Open study on PubMed →

Curcumin Inhibits Bladder Cancer by Inhibiting Invasion via AKT/MMP14 Pathway.

2024 · Metastasis and invasion

Finally, AKT, MMP14, E-cadherin and N-cadherin were analyzed by Western blot assay to confirm whether curcumin could inhibit bladder cancer by inhibiting invasion via AKT/MMP14 pathway.

Open study on PubMed →

Curcumin inhibits epithelial-mesenchymal transition in oral cancer cells via c-Met blockade.

2020 · Metastasis and invasion

In conclusion, the results of the present study demonstrated that curcumin was able to reverse HGF-induced EMT, possibly by inhibiting c-Met expression in oral cancer cells, providing a strong basis for the development of novel approaches for the treatment of oral cancer.

Open study on PubMed →

Curcumin inhibits the development of colorectal cancer via regulating the USP4/LAMP3 pathway.

2024 · Metastasis and invasion

Curcumin significantly accelerated cell apoptosis, and inhibited cell proliferation and invasion in LoVo and HCT-116 cells.

Open study on PubMed →

Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway.

2022 · Metastasis and invasion

Modern pharmacological studies have found that curcumin has many kinds of pharmacological activities of anti-inflammatory, anti-tumor, anti-angiogenesis, anti-metastasis and anti-multidrug resistance.

Open study on PubMed →

Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis.

2020 · Metastasis and invasion

Curcumin (20 and 30 μM) inhibited the proliferation, migration and invasion, and promoted the apoptosis of MCF-7 and MDA-MB-231 cells.

Open study on PubMed →

Curcumin suppresses HNSCC tumorigenesis through directly targeting FOSL1/JUN.

2026 · Metastasis and invasion

Comparative analyses of three anti-cancer natural products, including curcumin, gingerol, and allicin, revealed that only curcumin robustly inhibited HNSCC cell proliferation, invasion, and cancer stem cell self-renewal, with potency comparable or superior to cisplatin.

Open study on PubMed →

Curcumin-based polymer prodrug nanoplatform for high-efficiency immunotherapy by synergistically suppression of head and neck cancer cell stemness.

2025 · Metastasis and invasion

This multimodal mechanism significantly inhibited primary tumor growth and metastasis in HNC models, while extending survival.

Open study on PubMed →

Effect of curcumin on glioblastoma cells.

2019 · Metastasis and invasion

In conclusion, we have shown that nano micelles curcumin effectively prevent proliferation, and invasion of GBM cells through perturbation of Wnt/β-catenin and NF-κB pathways, suggesting further investigations on the therapeutic application of this novel anticancer drug in in vivo models.

Open study on PubMed →

H3K18la-PSMG1 Axis in Bladder Cancer Progression: Curcumin as a Therapeutic Candidate.

2026 · Metastasis and invasion

Experimental analyses revealed that PSMG1 was markedly upregulated in bladder cancer (BCa), progressively upregulated from normal tissue to MIBC, and PSMG1 silencing reduced cell proliferation, invasion, and clonogenic capacity in vitro, while attenuating tumor growth in vivo.

Open study on PubMed →

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells.

2017 · Metastasis and invasion

Because it has chemopreventive and anti-invasive effect against various cancer cells, EGCG can be used to inhibit proliferation and invasion of cholangiocarcinoma (CCA) cells.

Open study on PubMed →

Epigallocatechin-3-gallate inhibits migration of human nasopharyngeal carcinoma cells by repressing MMP-2 expression.

2019 · Metastasis and invasion

The results revealed that EGCG considerably inhibited the migration abilities of three NPC cells.

Open study on PubMed →

Epigallocatechin-3-gallate suppresses the growth of human osteosarcoma by inhibiting the Wnt/β-catenin signalling pathway.

2022 · Metastasis and invasion

Here, cellular experiments showed that EGCG significantly promoted OS cell apoptosis and inhibited proliferation, migration and invasion, and cell and animal experiments demonstrated that the Wnt/β-catenin pathway played an indispensable role in the antitumour effects of EGCG.

Open study on PubMed →

Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer.

2022 · Metastasis and invasion

Ginsenosides can reportedly induce tumor cell death, invasion, and metastasis; however, poor water solubility, low oral absorption rate, and rapid blood clearance limit their clinical application.

Open study on PubMed →

Ginsenoside Rd inhibits migration and invasion of tongue cancer cells through H19/miR-675-5p/CDH1 axis.

2022 · Metastasis and invasion

Ginsenoside Rd inhibits tongue cancer cell migration and invasion via the H19/miR-675-5p/CDH1 axis.

Open study on PubMed →

Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1/HSPB1/NCOA4.

2024 · Metastasis and invasion

We aim to study whether ginsenoside Rg5 exerted inhibitory effects on crucial aspects of glioma stem cells, including cell viability, tumor initiation, invasion, self-renewal ability, neurosphere formation, and stemness.

Open study on PubMed →

Rosmarinic acid in combination with ginsenoside Rg1 suppresses colon cancer metastasis via co-inhition of COX-2 and PD1/PD-L1 signaling axis.

2024 · Metastasis and invasion

To address this challenge, it is vital to identify traditional Chinese medicine components that modulate COX-2 and PD-1/PD-L1: rosmarinic acid (RA) exerts striking inhibitory effect on COX-2, while ginsenoside Rg1 (GR) possesses the potential to suppress the binding of PD-1/PD-L1.

Open study on PubMed →

Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism.

2023 · Metastasis and invasion

Glutathione peroxidase-2 (GPx2) plays various roles in tumor progression and patient survival.

Open study on PubMed →

Inhibition of glutathione peroxidase 4 suppresses gastric cancer peritoneal metastasis via regulation of RCC2 homeostasis.

2025 · Metastasis and invasion

Glutathione peroxidase 4 (GPx4), a key regulator of ferroptosis and redox homeostasis, contributes to progression and influences patient survival.

Open study on PubMed →

Effects of Melatonin and Doxorubicin on Primary Tumor And Metastasis in Breast Cancer Model.

2022 · Metastasis and invasion

Tumor growth and metastasis were markedly suppressed in melatonin alone and in combination with doxorubicin.

Open study on PubMed →

Hierarchical Disruption of the Tryptophan-Melatonin Axis Contributes to Glioma Progression Through AKT/ERK/STAT3 Signalling.

2026 · Metastasis and invasion

Restoration of these factors suppressed glioma cell proliferation, migration and invasion while promoting apoptosis.

Open study on PubMed →

Melatonin Exerts Anticancer Effects in Human Tongue Squamous Cell Carcinoma Cells by Promoting Autophagy.

2020 · Metastasis and invasion

We found that melatonin treatment significantly reduced the viability and colony formation ability of SCC-25 cells, impairing cell migration and invasion.

Open study on PubMed →

Melatonin inhibits breast cancer cell invasion through modulating DJ-1/KLF17/ID-1 signaling pathway.

2019 · Metastasis and invasion

Melatonin and taxol clearly decreased cell migration and invasion at low doses, especially those matching the normal physiological concentration at night.

Open study on PubMed →

Melatonin Inhibits EMT in Bladder Cancer by Targeting Autophagy.

2022 · Metastasis and invasion

The mechanisms of action of melatonin against tumor progression involve cellular apoptosis, antimetastatic activity, antioxidant and mutagenic effects, antiangiogenic activity, and the restoration of cancer immune surveillance.

Open study on PubMed →

Melatonin represses oral squamous cell carcinoma metastasis by inhibiting tumor-associated neutrophils.

2017 · Metastasis and invasion

Overall, The beneficial roles of melatonin in retarding OSCC metastasis were implicated with inhibition of TANs.

Open study on PubMed →

Targeting mitochondrial ribosomal protein expression by andrographolide and melatonin for colon cancer treatment.

2025 · Metastasis and invasion

Little is known about the role of mitochondria in the survival and metastatic ability of CSCs.

Open study on PubMed →

The evaluation of melatonin and EGF interaction on breast cancer metastasis.

2024 · Metastasis and invasion

The results of this study show that melatonin in the presence of EGF does not show the anti-cancer properties previously described for this substance.

Open study on PubMed →

Butyrate derived from intratumoral microbiome facilitates pulmonary metastasis in osteosarcoma.

2025 · Metastasis and invasion

Here, we integrated multiomics integration of 16S rRNA sequencing and circulating microbial DNA (cmDNA) profiling to investigate intratumoral microbiome dynamics in osteosarcoma pulmonary metastasis.

Open study on PubMed →

Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression.

2024 · Metastasis and invasion

Further assays revealed that Streptococcus anginosus (SA) promoted tumour cell proliferation and metastasis while suppressing the differentiation and infiltration of CD8+ T cells.

Open study on PubMed →

Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma.

2024 · Survival and clinical response

Higher tumor microbial α diversity was associated with lymph node metastasis and predicted shortened overall survival (OS) and recurrence-free survival (RFS).

Open study on PubMed →

Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway.

2024 · Metastasis and invasion

Furthermore, ECH-reshaped or F.p-colonized microbiota with a high butyrate-producing capability inhibited liver metastasis by suppressing PI3K/AKT signaling and reversing the epithelial-mesenchymal transition (EMT) process, whereas this anti-metastatic ability was abrogated by the butyrate synthase inhibitor heptanoyl-CoA.

Open study on PubMed →

Gut microbiome and serum metabolome alterations in osteosarcoma patients.

2025 · Metastasis and invasion

Gut microbiota has been shown to initiate tumorigenesis and cancer metastasis in multiple cancer types.

Open study on PubMed →

Gut microbiota and glycochenodeoxycholic role in liver metastasis of breast cancer.

2025 · Metastasis and invasion

In vitro experiments showed that GCDC inhibited breast cancer cell proliferation, migration, and invasion while inducing cell death.

Open study on PubMed →

Gut microbiota-dependent modulation of pre-metastatic niches by Jianpi Yangzheng decoction in the prevention of lung metastasis of gastric cancer.

2024 · Metastasis and invasion

Mechanically, JPYZ treatment not only prevented the alteration in gut microbiota structure, but also restored the SCFAs content induced by GC cells administration.

Open study on PubMed →

Integration of gut microbiome and lipid metabolism reveals the anti-cancer effects of pentadecanoic acid on bladder cancer.

2025 · Metastasis and invasion

PEA suppressed EJ and T24 BC cell migration, invasion, and proliferation, while inhibiting BC development in a BBN-induced mouse model.

Open study on PubMed →

Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer.

2022 · Metastasis and invasion

Taken together, we show that modulating the gut microbiota through antibiotics, HFD-FMT, or by administering LPS influenced TNBC chemotherapy responsiveness, lung metastasis, and intestinal inflammation.

Open study on PubMed →

Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation.

2022 · Metastasis and invasion

Further mice investigations demonstrated that TFENs after intravenous (i.v.) injection or oral administration could accumulate in breast tumors and lung metastatic sites, inhibit the growth and metastasis of breast cancer, and modulate gut microbiota.

Open study on PubMed →

The Role of Intratumor Microbiomes in Cervical Cancer Metastasis.

2023 · Metastasis and invasion

The relationship between intratumor microbiomes and cervical cancer metastasis, however, remains unclear.

Open study on PubMed →

ERRATUM: Quercetin Inhibits Intrahepatic Cholangiocarcinoma by Inducing Ferroptosis and Inhibiting Invasion via the NF-[Formula: see text]B Pathway.

2023 · Metastasis and invasion

The study reports eRRATUM: Quercetin Inhibits Intrahepatic Cholangiocarcinoma by Inducing Ferroptosis and Inhibiting Invasion via the NF-[Formula: see text]B Pathway.

Open study on PubMed →

Mechanism of Quercetin and Luteolin on Colon Cancer Metastasis: Network Pharmacological Study and Experimental Validation.

2026 · Metastasis and invasion

Quercetin (QCT) and luteolin (LTL) are anticancer herbal compounds.

Open study on PubMed →

Quercetin and Glioma: Which Signaling Pathways are Involved?

2022 · Metastasis and invasion

Multiple lines of evidence have shown that Quercetin has anti-tumor effects, documenting this natural compound exerts its pharmacological effects by targeting a variety of cellular and molecular processes, i.e., apoptosis, metastasis, and autophagy.

Open study on PubMed →

Quercetin induces MGMT+ glioblastoma cells apoptosis via dual inhibition of Wnt3a/β-Catenin and Akt/NF-κB signaling pathways.

2023 · Metastasis and invasion

Quercetin significantly suppressed the growth and migration of human GBM T98G cells, induced apoptosis, and arrested cells in the S-phase cell cycle.

Open study on PubMed →

Quercetin inhibits invasion and angiogenesis of esophageal cancer cells.

2021 · Metastasis and invasion

The migration distance and the number of invasive cells were significantly reduced in the 10 μg/mL quercetin group.

Open study on PubMed →

Quercetin Inhibits the Progression of Gastric Cancer Through the AKT/MAPK Signaling Pathway.

2026 · Metastasis and invasion

In vitro, quercetin dose-dependently inhibited cell proliferation, suppressed migration, and induced apoptosis through increasing Bax while decreasing Bcl-2 expression.

Open study on PubMed →

Quercetin Suppresses Human Glioblastoma Migration and Invasion via GSK3β/β-catenin/ZEB1 Signaling Pathway.

2022 · Metastasis and invasion

Our results showed that quercetin markedly suppressed the viability of glioblastoma cells in vitro and in vivo, and significantly inhibited glioblastoma cell migration and invasion.

Open study on PubMed →

Phosphatidylinositol 3-kinase and mechanistic target of rapamycin dualinhibitor, VDC597, as a therapeutic agent for canine osteosarcoma.

2025 · Metastasis and invasion

The results of this study demonstrate reduced signal transduction; increased cell death; reduced cell proliferation, migration, invasion, and vascular endothelial growth factor production in vitro; as well as reduced tumor growth and greater survival times with inhibition of PI3K-AKT-mTOR signaling in a xenograft mouse model.

Open study on PubMed →

Rapamycin Induces Phenotypic Alterations in Oral Cancer Cells That May Facilitate Antitumor T Cell Responses.

2024 · Metastasis and invasion

Rapamycin treatment significantly inhibited OSCC cell proliferation and migration, increased apoptotic cell death, and upregulated cell surface expression of several immune accessory and adhesion molecules, including CD40, CD83, PD-L1, PD-L2, MHC class I, P-selectin, and VCAM-1.

Open study on PubMed →

Effect of gold-conjugated resveratrol nanoparticles on glioma cells and its underlying mechanism.

2024 · Metastasis and invasion

Rsv-AuNPs treatment significantly suppressed proliferation, migration, and invasion of U87 cells (all P < 0.05) and increased the apoptosis rate (P < 0.05).

Open study on PubMed →

Effects of resveratrol and irradiation upon oral squamous cell carcinoma cells.

2014 · Metastasis and invasion

Resveratrol increases cytotoxic activity in the PE/CA-PJ15 cell line and reduces cell migration capacity, while the combination of resveratrol and irradiation exerts a synergic effect.

Open study on PubMed →

Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro.

2014 · Metastasis and invasion

Resveratrol inhibited the adhesion, migration, and invasion of OSCC cells in vitro, suggesting that it might serve as a chemopreventive agent for reducing the invasion and metastasis of OSCC.

Open study on PubMed →

Multiple Effects of Resveratrol on Osteosarcoma Cell Lines.

2022 · Metastasis and invasion

We found (1) a cell growth inhibition due to an increase in cell distress, which was, in part, due to the involvement of the AKT and caspase-3 pathways, (2) an increase in cellular differentiation due to major gene expression levels of the osteoblastic differentiation genes, (3) an inhibition of IL-6 secretion due to an epigenetic effect on the IL-6 promoter, and (4) an inhibition of OS cells migration related to the decrease in IL-8 secretion levels due to an epigenetic effect on its promoter.

Open study on PubMed →

Resveratrol and Cervical Cancer: A New Therapeutic Option.

2023 · Metastasis and invasion

Among the herb-based components, resveratrol has several beneficial effects given its anticancer activities (e.g., anti-angiogenesis, anti-proliferation, anti-metastatic and pro-apoptotic).

Open study on PubMed →

Resveratrol binds and activates RKIP protein in colorectal cancer.

2020 · Metastasis and invasion

Raf-1 kinase inhibitory protein (RKIP) acts as a tumor cell metastasis suppressor and prognostic indicator for survival in various cancers.

Open study on PubMed →

Resveratrol Decreases the Invasion Potential of Gastric Cancer Cells.

2022 · Metastasis and invasion

The cancer-preventive agent Resveratrol (RSV) [3,5,4'-trihydroxytrans-stilbene] is a widely recognized antioxidant molecule with antitumoral potential against several types of cancers, including prostate, hepatic, breast, skin, colorectal, and pancreatic.

Open study on PubMed →

Resveratrol in Cancer Treatment with a Focus on Breast Cancer.

2023 · Metastasis and invasion

Resveratrol can affect numerous signaling pathways in vitro, leading to the induction of cell cycle arrest and apoptosis, suppression of proliferation, reduction of inflammatory responses, and the inhibition of angiogenesis and metastasis.

Open study on PubMed →

Resveratrol Inhibits Nasopharyngeal Carcinoma (NPC) by Targeting the MAPK Signaling Pathway.

2024 · Metastasis and invasion

CCK-8, scratch wound, and transwell assays were employed to confirm the inhibitory effect of resveratrol on the proliferation, migration, and invasion of nasopharyngeal carcinoma cells.

Open study on PubMed →

Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway.

2022 · Metastasis and invasion

RSVL inhibited the migration, invasion, and growth of gastric cancer cells in concentration- and time-dependent manners.

Open study on PubMed →

Resveratrol restrains colorectal cancer metastasis by regulating miR-125b-5p/TRAF6 signaling axis.

2024 · Metastasis and invasion

Resveratrol, a polyphenolic compound has been shown to inhibit colorectal cancer metastasis in recent studies.

Open study on PubMed →

Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.

2017 · Metastasis and invasion

Resveratrol (RES) as a kind of phytoalexin has demonstrated anti-tumor functions in breast cancer and myeloid leukemia, but its function and mechanism are still unknown in gastric cancer treatment.

Open study on PubMed →

Resveratrol targets mitochondrial USP36-SOD2 to induce autophagy-ferroptosis and inhibit gastric cancer progression.

2025 · Metastasis and invasion

In vitro, resveratrol significantly inhibited gastric cancer cell proliferation and migration; in vivo, it suppressed tumor growth.

Open study on PubMed →

Zeb1 for RCP-induced oral cancer cell invasion and its suppression by resveratrol.

2020 · Metastasis and invasion

Notably, we provide evidence that resveratrol (REV) strongly inhibits RCP-induced Zeb1 expression through blocking β1 integrin endosome recycling and EGFR activation, leading to suppression of RCP-induced OSCC invasion, demonstrating the important role of RCP in OSCC invasion and its reversion by REV.

Open study on PubMed →

Inhibition of urinary bladder cancer cell proliferation by silibinin.

2020 · Metastasis and invasion

In conclusion, the silibinin inhibited the urinary bladder tumor cell proliferation independently of TP53 status; however, cell cycle effects, gene expression changes, and alteration of cell migration are dependent on TP53 status. © 2020 Wiley Periodicals, Inc.

Open study on PubMed →

Sulforaphane suppresses bladder cancer metastasis via blocking actin nucleation-mediated pseudopodia formation.

2024 · Metastasis and invasion

Here, we unravel the effects of sulforaphane (SFN), an isothiocyanate in cruciferous vegetables, on the assembly of pseudopodia and BC metastasis, and its molecular mechanism in the process.

Open study on PubMed →

Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway.

2022 · Metastasis and invasion

Here, we showed that SFN, including its two isomers of R-SFN and S-SFN, significantly inhibited TGF-β1-induced migration and invasion in breast cancer cells.

Open study on PubMed →

Sulforaphane suppresses oral cancer cell migration by regulating cathepsin S expression.

2018 · Metastasis and invasion

Sulforaphane has been demonstrated to exert numerous biological effects, such as neuroprotective, anti-inflammatory, and anticancer effects.

Open study on PubMed →

Glioblastoma Invasiveness and Collagen Secretion Are Enhanced by Vitamin C.

2022 · Metastasis and invasion

Finally, orthotopic xenografts induced in immunocompetent guinea pigs showed that vitamin C deficiency retained collagen, reduced blood vessel invasion, and affected glomeruloid vasculature formation, all pathological conditions associated with malignancy.

Open study on PubMed →

High-dose vitamin D metabolite delivery inhibits breast cancer metastasis.

2022 · Metastasis and invasion

When administered to mice, this nanosystem demonstrates high calcitriol doses in breast tumor cells, significant tumor growth inhibition and antimetastasis capability, as well as good biocompatibility.

Open study on PubMed →

Scottsdale Clinic

14200 N Northsight Blvd #160
Scottsdale, Arizona 85260

Office Hours

Monday–Friday: 9:00 AM–5:00 PM
Saturday: 9:00 AM–12:00 PM

Visit Sunridge in Scottsdale

FREE INTRODUCTORY CALL

Speak With Our Patient Care Team

Tell us what you are facing. There is no charge to speak with our Patient Care Team, understand how Sunridge works and determine whether a physician consultation may be an appropriate next step.

Call Now: 1-800-923-7878

This introductory call is not a medical consultation and does not establish a physician-patient relationship.

Have a Question or Share Feedback:
It's easy to get in touch with us